Alfentanil with methohexitone in paediatric dental anaesthesia

Area of Science:

• Pediatric Anesthesiology
• Pharmacology

Background:

• Emergence from anesthesia in children undergoing dental procedures can involve distress, including crying and confusion.
• This emergence delirium is unsettling for patients, parents, and hospital staff.

Purpose of the Study:

• To evaluate the efficacy of alfentanil as an adjunct to methohexitone anesthesia in mitigating emergence agitation in pediatric dental patients.
• To determine the optimal dose of alfentanil for reducing post-anesthesia emergence phenomena.

Main Methods:

• A randomized controlled trial involving pediatric patients undergoing simple dental extractions under intravenous methohexitone anesthesia.
• Patients received either methohexitone alone (control) or methohexitone combined with varying doses of alfentanil (2.5, 5.0, 7.5, 10 mcg/kg).
• Incidence and onset of crying and emergence agitation were assessed and compared across groups.

Main Results:

• The highest dose of alfentanil (10 mcg/kg) significantly reduced the incidence of crying compared to methohexitone alone and lower alfentanil doses.
• A significant delay in the onset of crying was observed in the group receiving the highest alfentanil dose.
• No adverse effects were reported in any of the alfentanil treatment groups.

Conclusions:

• Alfentanil, particularly at a dose of 10 mcg/kg, is an effective adjunct to methohexitone for reducing emergence agitation in children after dental extractions.
• This pharmacological approach offers a safe and effective strategy to improve the recovery experience for pediatric patients and their families.